Information for Healthcare Professionals

Diagnosis of any type of Congenital disorders of glycosylation (CDG) is still very rare and some heathcare professionals are still unfamiliar with either diagnosis or current research.

Find more information here:

International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

We work in partnership with the Portuguese Association CDG and Rare Metabolic Diseases (APCDG-DMR), a global voice to fight the impact of Rare Metabolic Diseases on affected individuals and their families. Every two years they host the World Conferences on CDG for healthcare professionals and families.

Learn more here.


Want to know about the latest research?


%d bloggers like this: